Related Experiment Video
Updated: Nov 4, 2025

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
Including random centre effects in design, analysis and presentation of multi-centre trials
Kate Edgar1, Ian Roberts2, Linda Sharples3
1Department of Medical Statistics, LSHTM, Keppel Street, London, WC1E 7HT, UK.
Large multicentre trials require careful consideration of centre variation. This study found significant variation in outcomes but not treatment effects, clarifying multi-level model use for binary outcomes.
Area of Science:
- Clinical Trials Methodology
- Biostatistics
- Health Services Research
Background:
- Uncertainty exists regarding the necessity of adjusting for centre variation in large, diverse multicentre trials.
- A critical distinction lies between variations in outcomes (independent of treatment) and variations in treatment effects.
- This study re-analyzes the CRASH-2 trial to clarify the application of multi-level models for binary outcomes in multicentre settings.
Purpose of the Study:
- To clarify when and how to use multi-level models for multicentre studies with binary outcomes.
- To distinguish between variation in outcome and variation in treatment effect in large clinical trials.
- To re-analyze the CRASH-2 trial data to inform statistical design and analysis strategies.
Main Methods:
- Reanalysis of the CRASH-2 trial data, which randomized 20,127 trauma patients across 271 centres and 40 countries.
- Utilized logistic regression models with fixed effects for treatment, patient-level, and centre-level baseline covariates.
- Incorporated random effects to assess variation between countries and between centres within countries in both underlying risk of death and treatment effect.
Main Results:
- Significant variation was observed between countries and centres regarding the 4-week all-cause death outcome.
- No differences were found between countries or centres in the treatment effect of tranexamic acid.
- The average treatment effect remained unchanged after accounting for centre and country variation.
Conclusions:
- Distinguishing between underlying outcome variation and treatment effect variation is crucial; outcome variation is common, but treatment effect variation is not.
- Stratifying randomization by centre can resolve numerous statistical challenges in multicentre trials.
- Including random intercepts in the analysis may enhance statistical power and reduce bias in mean and standard error estimates.
More Related Videos
Related Concept Videos
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Study Design in Statistics
Does aspirin reduce the risk of heart attacks? Is one brand of fertilizer more effective at growing roses than another? Is fatigue as dangerous to a driver as the influence of alcohol? Questions like these are answered using randomized experiments with proper...
Randomized Experiments
Simple randomization
Simple...
Study Designs in Epidemiology
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
Factorial Design

